Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenetics of chronic obstructive pulmonary disease.

Pharmacogenomics - 1 Jul 2013

Hizawa Nobuyuki

Abstract excerpt

Chronic obstructive pulmonary disease (COPD) is a complex genetic disease that develops as a result of the interaction of multiple susceptibility genes and environmental factors. Major therapeutic approaches include smoking cessation, treatment with bronchodilators and corticosteroid therapy. The...

Topics

Bronchodilator Agents
Humans
Pharmacogenetics
Phenotype
Pulmonary Disease, Chronic Obstructive
Receptors, Adrenergic, beta-2
Smoking Cessation

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 23859575
DOI: 10.2217/pgs.13.107

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026. Prepared record publication-23859575-2026-08-30.1. Manifest publication-graph-cohort-2026-08-30.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenetics of chronic obstructive pulmonary disease.PMID 23859575Read ↗

Pharmacogenetics of chronic obstructive pulmonary disease: challenges and opportunities.Semantic proximity Read ↗

Genetics of chronic obstructive pulmonary disease: understanding the pathobiology and heterogeneity of a complex disorder.Semantic proximity Read ↗

Effect of polymorphisms in the β2-adrenergic receptor on the susceptibility and pulmonary function of patients with chronic obstructive pulmonary disease: a meta analysis.Semantic proximity Read ↗

[Chronic obstructive pulmonary disease and genetics].Semantic proximity Read ↗

[Genetics of chronic obstructive pulmonary disease].Semantic proximity Read ↗

The impact of genomic variants on patient response to inhaled bronchodilators: a comprehensive update.Semantic proximity Read ↗

Genetics of COPD.Semantic proximity Read ↗

Gene polymorphisms and chronic obstructive pulmonary disease.Semantic proximity Read ↗

Genetics of chronic respiratory disease.Semantic proximity Read ↗

Pharmacogenetics of β2-AgonistsSemantic proximity Read ↗

Pharmacogenetic and pharmacogenomic considerations of asthma treatment.Semantic proximity Read ↗

Pharmacological Management of Chronic Obstructive Lung Disease (COPD). Focus on Mutations - Part 1.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.